Kraj: Unia Europejska
Język: angielski
Źródło: EMA (European Medicines Agency)
ritonavir
AbbVie Deutschland GmbH Co. KG
J05AE03
ritonavir
Antivirals for systemic use,
HIV Infections
Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1-infected patients (adults and children of two years of age and older).,
Revision: 61
Authorised
1996-08-25
124 B. PACKAGE LEAFLET 125 PACKAGE LEAFLET: INFORMATION FOR THE USER NORVIR 80 MG/ML ORAL SOLUTION ritonavir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU OR YOUR CHILD. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET : 1. What Norvir is and what it is used for 2. What you need to know before you or your child takes Norvir 3. How to take Norvir 4. Possible side effects 5. How to store Norvir 6. Contents of the pack and other information 1. WHAT NORVIR IS AND WHAT IT IS USED FOR Norvir contains the active substance ritonavir. Norvir is a protease inhibitor used to control HIV infection. Norvir is used in combination with other anti-HIV medicines (antiretrovirals) to control your HIV infection. Your doctor will discuss with you the best combination of medicines for you. Norvir is used by children 2 years of age or older, adolescents and adults who are infected with HIV, the virus which causes AIDS. 2. WHAT YOU NEED TO KNOW BEFORE YOU OR YOUR CHILD TAKES NORVIR DO NOT TAKE NORVIR − if you are allergic to ritonavir or any of the other ingredients of Norvir (see section 6). − if you have severe liver disease. − if you are currently taking any of the following medicines: − astemizole or terfenadine (commonly used to treat allergy symptoms – these medicines may be available without prescription); − amiodarone, bepridil, dronedarone, encainide, flecainide, propafenone, quinidine (used to correct irregular heartbeats); − dihydroergotamine, ergotamine (used to treat migraine headache); − ergonovine, methylergonovine (used to stop exces Przeczytaj cały dokument
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Norvir 80 mg/ml oral solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of oral solution contains 80 mg of ritonavir. Excipients with known effect: Alcohol (43.2 % v/v) Propylene glycol (26.0% v/v) Polyoxyl 35 Castor Oil Sunset Yellow (E110) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral solution The solution is a practically clear, orange solution for oral administration. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ritonavir is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infected patients (adults and children of 2 years of age and older). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Ritonavir should be administered by physicians who are experienced in the treatment of HIV infection. Norvir solution is administered orally and should preferably be ingested with food. Posology _Ritonavir dosed as a pharmacokinetic enhancer _ When ritonavir is used as a pharmacokinetic enhancer with other protease inhibitors the Summary of Product Characteristics for the particular protease inhibitor must be consulted. The following HIV-1 protease inhibitors have been approved for use with ritonavir as a pharmacokinetic enhancer at the noted doses. _Adults _ Amprenavir 600 mg twice daily with ritonavir 100 mg twice daily. Atazanavir 300 mg once daily with ritonavir 100 mg once daily. Fosamprenavir 700 mg twice daily with ritonavir 100 mg twice daily. Lopinavir co-formulated with ritonavir (lopinavir/ritonavir) 400 mg/100 mg or 800 mg/200 mg. Saquinavir 1000 mg twice daily with ritonavir 100 mg twice daily in ART experienced patients. Initiate treatment with saquinavir 500 mg twice daily with ritonavir 100 mg twice daily for the 3 first 7 days, then saquinavir 1000 mg twice daily with ritonavir 100 mg twice daily in ART- naïve patients. Tipranavir 500 mg twice daily with ritonavir 200 mg twice daily. Tipranavir with ritonavir should not be used in treatment-naïve pati Przeczytaj cały dokument